We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $810M
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
+10.59%
1 Year Est. Return
+30.2%
3 Year Est. Return
+116.38%
5 Year Est. Return
+153.13%
10 Year Est. Return
+962.25%
AUM
$998M
AUM Growth
+$20.9M
Cap. Flow
-$63M
Cap. Flow %
-6.31%
Top 10 Hldgs %
28.11%
Holding
91
New
2
Increased
24
Reduced
43
Closed
3

Sector Composition

Rank Sector Weight
1 Healthcare 91.36%
2 Financials 1.12%
3 Technology 0.14%
4 Energy 0.14%
5 Communication Services 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
76
JPMorgan Chase
JPM
$950B
$420K 0.04%
3,726
-509
-12% -$57.8K
DIS icon
77
Walt Disney
DIS
$181B
$407K 0.04%
3,483
PFE icon
78
Pfizer
PFE
$153B
$386K 0.04%
9,227
HAL icon
79
Halliburton
HAL
$26.6B
$374K 0.04%
9,221
IBM icon
80
IBM
IBM
$224B
$372K 0.04%
2,574
BUD icon
81
AB InBev
BUD
$165B
$332K 0.03%
3,788
MSFT icon
82
Microsoft
MSFT
$3.71T
$330K 0.03%
2,887
JHG
83
DELISTED
Janus Henderson
JHG
$319K 0.03%
11,828
WFC icon
84
Wells Fargo
WFC
$264B
$308K 0.03%
5,858
F icon
85
Ford
F
$55.7B
$300K 0.03%
32,405
GOOGL icon
86
Alphabet (Google) Class A
GOOGL
$4.33T
$215K 0.02%
3,560
GEN icon
87
Gen Digital
GEN
$17.5B
$207K 0.02%
9,734
-2,901
-23% -$59.1K
RGLS
88
DELISTED
Regulus Therapeutics
RGLS
$97K 0.01%
4,107
ACAD icon
89
Acadia Pharmaceuticals
ACAD
$5.03B
-220,000
Closed -$3.36M
JNJ icon
90
Johnson & Johnson
JNJ
$625B
-60,000
Closed -$7.28M
ESRX
91
DELISTED
Express Scripts Holding Company
ESRX
-295,000
Closed -$22.8M

Similar funds

Rhenman & Partners Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Rhenman & Partners Asset Management held 91 positions worth $998M, up 2.1% from $977M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Rhenman & Partners Asset Management withdrew a net $63M in Q3 2018, closing 3 positions and reducing 43 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 92% a quarter earlier, followed by Financials and Technology.

Against the trend, Rhenman & Partners Asset Management opened a new position in Pediatrix Medical worth $5.82M.

  • Rhenman & Partners Asset Management's largest Q3 2018 buy was Pediatrix Medical: 124,674 shares worth $5.82M.
  • Rhenman & Partners Asset Management added most to DIPLOMAT PHARMACY, INC. in Q3 2018, an estimated $22M increase.
  • Rhenman & Partners Asset Management's biggest Q3 2018 reduction was Nektar Therapeutics, cutting an estimated $17.8M.
  • Rhenman & Partners Asset Management fully exited Express Scripts Holding Company in Q3 2018, selling an estimated $22.8M.
  • Rhenman & Partners Asset Management's ten largest holdings make up 28% of its $998M portfolio in Q3 2018.
  • Rhenman & Partners Asset Management opened 2 new positions and closed 3 in Q3 2018.
  • Rhenman & Partners Asset Management's portfolio value rose 2.1% quarter-over-quarter to $998M.

Based on Rhenman & Partners Asset Management's 13F filing for Q3 2018, filed 3 Oct 2018.